Who is sponsoring NCT03754881?

NCT03754881 is sponsored by Asan Medical Center.

What drugs are being tested in NCT03754881?

Interventions in NCT03754881: Pulmonary rehabilitation.

What condition does NCT03754881 study?

NCT03754881 studies Chronic Obstructive Pulmonary Disease.

Is NCT03754881 still recruiting?

NCT03754881 is currently completed. Last updated 1 June 2022.

Last reviewed 2022-06-01 · How we verify

NCT03754881

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of 8-week Supervision in Home Based Pulmonary Rehabilitation

Completed Last updated 1 June 2022

What this trial tests

trial testing Pulmonary rehabilitation in Chronic Obstructive Pulmonary Disease in 41 participants. Completed in 6 September 2020.

Timeline

1 September 2018

Primary endpoint
5 May 2019

6 September 2020

Quick facts

Lead sponsor	Asan Medical Center
Status	Completed
Study type	OBSERVATIONAL
Enrollment	41
Start date	1 September 2018
Primary completion	5 May 2019
Estimated completion	6 September 2020
Sites	1 location across South Korea

Drugs / interventions tested

Pulmonary rehabilitation

Conditions studied

Chronic Obstructive Pulmonary Disease — all drugs for Chronic Obstructive Pulmonary Disease →

Sponsor

Asan Medical Center

Who can join

40 and older, any sex, with Chronic Obstructive Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In korea, it is not easy to practice standard pulmonary rehabilitation (PR). in this study, we'll educate PR to patients and make reservation for re-visiting outpatients clinics with PR diary. we want to confirm whether patients, who perform home based PR during more than 30 minutes in 3 days per week, present improved dyspnea score or quality of life compared with non-compliance group.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Efficacy of Unsupervised Home-Based Pulmonary Rehabilitation for Patients with Chronic Obstructive Pulmonary Disease.
Lee JH, Lee HY, Jang Y, Lee JS, et al · · 2020 · cited 15× · PMID 33061347 · DOI 10.2147/copd.s268683
Efficacy Of Unsupervised Home-Based Pulmonary Rehabilitation For Patients With Chronic Obstructive Pulmonary Disease
Lee JH, Lee HY, Jang Y, Lee JS, et al · · 2020 · DOI 10.21203/rs.3.rs-35242/v1

Verify or expand the search:

Other trials of Pulmonary rehabilitation

Trials testing the same drug.

NCT07088185 — Pulmonary Outcomes on Patients With Lung Fibrosis · NA · active not recruiting
NCT06522724 — Education Impact on Rehabilitation of Hospitalized Patients With Pneumonia and COVID-19 · NA · completed
NCT06366113 — Time of Exercise Re-training With Chronic Obstructive Pulmonary Disease (COPD) · NA · recruiting
NCT06028711 — Education Impact on Rehabilitation of Hospitalized Patients with Chronic Obstructive Pulmonary Disease. · NA · completed
NCT06051136 — Early Versus Delayed Rehabilitation Intervention in Patients With Lung Cancer · NA · active not recruiting

Other recruiting trials for Chronic Obstructive Pulmonary Disease

Currently open trials in the same condition.

NCT06749262 — Inclined Versus Standard Exercise for COPD Patients · NA · recruiting
NCT07406659 — Different Inspiratory Muscle Trainings in Patients With COPD · NA · recruiting
NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting
NCT07418736 — A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease · Phase 2 · recruiting
NCT07069829 — Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo · recruiting

Other Asan Medical Center trials

Trials by the same sponsor.

NCT07530393 — Blood Viscosity and Outcomes After Elective Craniotomy · not yet recruiting
NCT07010497 — A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Be · Phase 2 · recruiting
NCT07382505 — Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cerv · not yet recruiting
NCT07489092 — Feasibility of a Digital Rehabilitation Platform in Patients After ICU Discharge · NA · recruiting
NCT07431762 — Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Hear · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03754881 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Asan Medical Center
Last refreshed: 1 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03754881.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing